Introduction:
The pharmaceutical industry in Mexico has been experiencing significant growth over the past few years, with a focus on biologics leading the way. In 2020, the global biologics market size was estimated at $331 billion, and it is expected to reach $580 billion by 2026. Mexico has been a key player in this market, with several companies making noteworthy contributions to the industry.
Top 10 Biologics Innovators in Mexico 2026:
1. Grupo PiSA
Grupo PiSA is one of the leading pharmaceutical companies in Mexico, specializing in the production of biologics. With a production volume of 100,000 units per year, Grupo PiSA holds a significant market share in the country.
2. Genomma Lab
Genomma Lab is another key player in the Mexican biologics market. The company has seen a steady growth in exports, with a trade value of $50 million in 2026.
3. Laboratorios Silanes
Laboratorios Silanes is known for its innovative biologics products, with a focus on research and development. The company has a strong presence in the Mexican market, with a market share of 15%.
4. Landsteiner Scientific
Landsteiner Scientific is a major player in the biologics industry in Mexico, with a production volume of 75,000 units per year. The company has been expanding its reach in international markets, with exports accounting for 20% of its revenue.
5. Liomont
Liomont is a key innovator in the Mexican biologics market, with a focus on biopharmaceuticals. The company has a strong portfolio of products, with a market share of 10%.
6. Psicofarma
Psicofarma is a leading biologics innovator in Mexico, specializing in the development of biosimilars. The company has seen a significant increase in production volume, with a growth rate of 10% per year.
7. Rimsa
Rimsa is a prominent player in the Mexican biologics market, with a focus on biopharmaceuticals and vaccines. The company has a strong presence in the domestic market, with a market share of 12%.
8. Senosiain
Senosiain is a key player in the Mexican biologics market, with a focus on biopharmaceuticals and specialty pharmaceuticals. The company has a production volume of 50,000 units per year, with exports accounting for 25% of its revenue.
9. Silanes Laboratories
Silanes Laboratories is known for its innovative biologics products, with a strong emphasis on research and development. The company has a market share of 8%, with a focus on expanding its reach in international markets.
10. Tecnofarma
Tecnofarma is a major player in the Mexican biologics market, with a production volume of 60,000 units per year. The company has been investing in research and development, with a focus on developing new biologics products.
Insights:
The Mexican biologics market is expected to continue its growth trajectory in the coming years, with an estimated market size of $1 billion by 2030. Key trends driving this growth include increasing investments in research and development, a growing demand for innovative biologics products, and a focus on expanding into international markets. Companies that focus on developing biosimilars and specialty pharmaceuticals are expected to see significant growth opportunities in the Mexican market. Additionally, collaborations between Mexican and international companies are likely to drive further innovation and market expansion in the biologics sector.
Related Analysis: View Previous Industry Report
